Skip to main content
. 2019 Jul 17;11(7):996. doi: 10.3390/cancers11070996
NK natural killer
GBM glioblastoma
BTZ bortezomib
GM1 monosialotetrahexosylganglioside
TMZ temozolomide
HLA human leucocyte antigen
KIR killer immunoglobulin-like receptor
SHP-1/-2 Src-Homology 2 domain Phosphatase
MICA/B MHC chain-related antigen
ULBP UL16-binding protein
TNF tumour necrosis factor
IFN interferon
TRAIL TNF-related apoptosis-inducing ligand
DNAM-1 DNAX accessory molecule-1
ATP adenosine triphosphate
IC50 Half maximal inhibitory concentration
PARP-1 poly ADP-ribose polymerase-1
CQ chloroquine
GFP green fluorescent protein
MRI magnetic resonance imaging
Mlc-1 myeloid leukaemia cell differentiation protein
DMEM Dulbecco’s Modified Eagle’s medium
FBS fetal bovine serum
NEAA non-essential Amino Acid
REK regional committees for medical and health research ethics
NB Neural Basal medium
PBMCs Peripheral blood mononuclear cells
SC Stem Cell Growth Medium
ELISA Enzyme-linked immunosorbent assay
NHA normal human astrocytes
E:T effector:target
PBS phosphate-buffered saline
IR infrared
FMO fluorescent minus one
DAPI 4′,6-diamidino-2-phenylindole
OCR oxygen consumption rate
NOD/SCID non-obese diabetic/severe combined immunodeficiency
H&E hematoxylin and eosin
IHC immunohistochemistry
SEM standard error of the mean
ANOVA analysis of variance
UiB University of Bergen
PI propidium iodide
MFI mean of fluorescence intensity
IDH isocitrate dehydrogenase